Arrivent Biopharma

Arrivent Biopharma is a company listed under the stock ticker AVBP (US).

Acquisition, funding and merger involving Arrivent Biopharma.

• Arrivent Biopharma has just announced a $100 Million fundraising (posted on January 10 2024).
• Arrivent Biopharma has just announced a $155 Million fundraising (posted on March 29 2023).

View the org chart displaying its 22 main executives

Most searched biographies at Arrivent Biopharma

• Bing Yao, Chief Executive Officer and Director
• John Hohneker, Director
• Kristine Peterson, Director

Popular executive movements at Arrivent Biopharma

• John Hohneker has joined the company as Director  (posted on May 17 2024).
• Kristine Peterson has joined the company as Director  (posted on April 23 2024).
• Winston Kung has joined the company as Chief Financial Officer and Treasurer  (posted on January 8 2024).

Click here to view some more movements at Arrivent Biopharma

Create your alert
to follow the executive moves at Arrivent Biopharma.

Arrivent Biopharma has 2,294 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Arrivent Biopharma

• ArriVent Announces Pricing of Upsized Initial Public Offering | ArriVent Biopharma
• ArriVent Receives FDA Breakthrough Therapy Designation for Furmonertinib for First-Line Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations | ArriVent Biopharma
• InnoCare and ArriVent Announce Clinical Development Collaboration - ArriVent Biopharma
• ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing - ArriVent Biopharma

Social media about Arrivent Biopharma

• Arrivent Biopharma on Wikipedia, Google News & Yahoo Finance
• Arrivent Biopharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Bing Yao

Call Arrivent Biopharma at +1 914...

View the org chart

Register to receive your alert

Report an error